Safety and efficacy of immune checkpoint inhibitors in cancer patients with pre-existing autoimmune disease: A UK tertiary cancer centre experience

被引：1
|
作者：
Patel, G. [1 ]
Sawhney, P. [1 ]
Ohana, D. [1 ]
Luong, M. [1 ]
Wong, Y. N. S. [1 ]
Lee, A. J. X. [1 ]
Forster, M. [1 ]
机构：
[1] UCLH Univ Coll London Hosp NHS Fdn Trust, Oncol, London, England
来源：
ANNALS OF ONCOLOGY | 2021年 / 32卷
关键词：
D O I：
10.1016/j.annonc.2021.01.045
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
31P
引用
收藏
页码：S12 / S13
页数：2
相关论文
共 50 条
  • [1] Safety and efficacy of immune checkpoint inhibitors in NSCLC patients with autoimmune disease: A UK tertiary cancer centre experience
    Sawhney, P.
    Patel, G.
    Ohana, D.
    Luong, M. K.
    Wong, Y. N. S.
    Lee, A. J. X.
    Lee, S-M.
    Forster, M. D.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (04) : S810 - S810
  • [2] Safety of immune checkpoint inhibitors in patients with cancer and pre-existing autoimmune disease
    Alexander, Swetha
    Swami, Umang
    Kaur, Aneet
    Gao, Yubo
    Fatima, Munazza
    Ginn, Meredith M.
    Stein, Jill E.
    Grivas, Petros
    Zakharia, Yousef
    Singh, Namrata
    ANNALS OF TRANSLATIONAL MEDICINE, 2021, 9 (12)
  • [3] The safety and efficacy of immune-checkpoint inhibitors in patients with cancer and pre-existing autoimmune diseases
    Wu, Chunlan
    Zhong, Li
    Wu, Qing
    Lin, Shaowei
    Xie, Xianhe
    IMMUNOTHERAPY, 2021, 13 (06) : 527 - 540
  • [4] Safety of Immune Checkpoint Inhibitors in Patients Treated for Cancer with Pre-existing Autoimmune Diseases
    Kaur, Aneet
    Swami, Umang
    Fatima, Munazza
    Ginn, Meredith
    Stein, Jill
    Gao, Yubo
    Zakharia, Yousef
    Singh, Namrata
    ARTHRITIS & RHEUMATOLOGY, 2019, 71
  • [5] Safety profiles in the use of immune checkpoint inhibitors by patients with cancer and pre-existing autoimmune diseases
    Freitas, Julia de Almeida Santos
    Neto, Marinho Marques da Silva
    de Lima, Cleverton Kleiton Freitas
    Sorte, Ney Cristian Amaral Boa
    Bendicho, Maria Teresita
    Santos, Anibal de Freitas
    MEDICINA CLINICA, 2025, 164 (02): : 53 - 60
  • [6] Immune checkpoint inhibitors in patients with pre-existing psoriasis: safety and efficacy
    Halle, Briana Rose
    Betof Warner, Allison
    Zaman, Farzana Y.
    Haydon, Andrew
    Bhave, Prachi
    Dewan, Anna K.
    Ye, Fei
    Irlmeier, Rebecca
    Mehta, Paras
    Kurtansky, Nicholas R.
    Lacouture, Mario E.
    Hassel, Jessica C.
    Choi, Jacob S.
    Sosman, Jeffrey A.
    Chandra, Sunandana
    Otto, Tracey S.
    Sullivan, Ryan
    Mooradian, Meghan J.
    Chen, Steven T.
    Dimitriou, Florentia
    Long, Georgina
    Carlino, Matteo
    Menzies, Alexander
    Johnson, Douglas B.
    Rotemberg, Veronica M.
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2021, 9 (10)
  • [7] Safety and effectiveness of immune checkpoint inhibitor therapy in patients with lung cancer and pre-existing autoimmune disease
    Goutam, S.
    Raghavan, A.
    Meyers, D. E.
    Dawe, D.
    Oneil, L.
    Graham, J.
    ANNALS OF ONCOLOGY, 2024, 35 : S870 - S870
  • [8] Immune checkpoint inhibitors in cancer patients with autoimmune disease: Safety and efficacy
    Le, Jiayuan
    Sun, Yuming
    Deng, Guangtong
    Dian, Yating
    Xie, Yanli
    Zeng, Furong
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2025, 21 (01)
  • [9] Immune checkpoint inhibitors for patients with pre-existing autoimmune diseases
    Maeda, Osamu
    NAGOYA JOURNAL OF MEDICAL SCIENCE, 2023, 85 (01) : 33 - 34
  • [10] Learning Needs of Patients with Cancer and a Pre-Existing Autoimmune Disease Who Are Candidates to Receive Immune Checkpoint Inhibitors
    Lopez-Olivo, Maria A.
    Kachira, Johncy J.
    Buni, Maryam
    Kim, Sang Taek
    Lu, Huifang
    Tayar, Jean H.
    Duhon, Gabrielle F.
    Ruiz, Juan I.
    Bingham III, Clifton O.
    Calabrese, Cassandra
    Volk, Robert J.
    Suarez-Almazor, Maria E.
    CANCERS, 2023, 15 (15)
12345